Article
Update on genetics and epigenetics in metabolic associated fatty liver disease
1 Jan 2022
Abstract excerpt
Nonalcoholic fatty liver disease (NAFLD) is becoming the most frequent chronic liver disease worldwide. Metabolic (dysfunction) associated fatty liver disease (MAFLD) is suggested to replace the nomenclature of NAFLD. For individuals with metabolic dysfunction, multiple NAFLD-related factors also contribute to the development and progression of MAFLD including genetics and epigenetics. The application of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
